Акционерное общество "ТВ БРИКС"
tvbrics@tvbrics.com
Рубцов переулок, д.13, Москва, 105082, RU
+74996425304
Currencies:
RUB/USD 0,0139
0,0000
BRL/USD 0,1932
0,0000
INR/USD 0,0104
0,0000
CNY/USD 0,1475
0,0000
ZAR/USD 0,0605
0,0000
IDR/USD 0,0001
0,0000

INTERNATIONAL

MEDIA

NETWORK

Menu
Home
News
Videos
Podcasts
Menu
22:30 «Lеt's be clear»
22:30 «Lеt's be clear»
Now 16+
22:30

«Lеt's be clear»

It is indicated Moscow time in the programme. Please take into account the time difference with your time zone.
23:00 «BRICSreport»
Next
23:00

«BRICSreport»

16+
00:00

Documentary film «Charming Beijing!»

16+
00:00

Documentary film «Charming Beijing!»

16+
10.06.2616:05 Society
Availability of vaccines and development of pharmaceutical sector in Global South
08.06.2618:00 Economy
Knowledge as raw material: why education and science are becoming foundation of future economy
01.06.2617:00 Economy
Global justice in healthcare: BRICS cooperation in production of medical technologies
10.06.2612:00 Society
Residents of BRICS+ countries to watch television programmes about Southern Urals
07.06.2610:00 Society
One of Russia’s largest economic universities and TV BRICS announce strategic cooperation at SPIEF 2026
06.06.2610:00 Culture
TV BRICS and "Gateway to Russia" project to jointly promote Russian language and culture abroad
TV BRICS
Iran
18.10.24 08:31
Society

New Iranian anti-cancer drug promises longer life without common side effects

It will minimise common side effects such as hair loss and weight loss


An Iranian biotech company has announced the development of an innovative anti-cancer drug that promises to extend the lives of patients while minimising common side effects such as hair loss and weight loss. This is reported by ParsToday, a partner of TV BRICS.

The new therapy utilises antibody–drug conjugates or ADCs technology, which enables the medication to directly target cancerous tissues. This combination of immunotherapy and chemotherapy delivers higher efficacy while reducing the dosage needed for treatment. 

It was introduced the drug, designed to treat breast cancer and certain digestive cancers. Experts say that the targeted approach not only enhances treatment effectiveness but also leads to significantly fewer adverse effects. 

Photo: iStock
Short
and to the point
Once a week we will cover news in the BRICS countries
By clicking on the "Subscribe" button, you agree to the processing of personal data

MORE ON THE TOPIC

11.06.2612:00 Society
Brazilian scientists identify new 400-million-year-old marine species in major fossil discovery
10.06.2616:05 Society
Availability of vaccines and development of pharmaceutical sector in Global South
10.06.2612:00 Society
Residents of BRICS+ countries to watch television programmes about Southern Urals
09.06.2618:00 Society
International students test their Russian language skills in team game during open lesson at BRICS+ Media Centre
09.06.2614:00 Society
Egypt to welcome Africa Health ExCon 2026 to explore future of digital healthcare in Africa
08.06.2612:00 Society
Tehran researchers develops light-activated cancer therapy
1 out of
Иконка с часами 24 minutes 26 sec.
Director General of Independent Evaluation Office of New Development Bank, Ashwani Muthoo: "Harmonisation of methodologies in evaluation for projects is critical"
Иконка с часами 32 minutes 31 sec.
Consultant in Economic Advisory Council to Prime Minister of India, Apurv Kumar Mishra: "There is strategic logic to economic partnership between Russia and India"
Иконка с часами 32 minutes 24 sec.
Spouse of Ambassador of Indonesia to Russia, Fitria Wibowo Tavares: “BRICS membership helps us so much in terms of addressing issues of common concern”
Short
and to the point
Once a week we will cover news in the BRICS countries
By clicking on the "Subscribe" button, you agree to the processing of personal data